![](https://webarchive.library.unt.edu/eot2008/20081010044217im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/eot2008/20081010044217im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/eot2008/20081010044217im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/eot2008/20081010044217im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081010044217im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081010044217im_/http://www.nci.nih.gov/images/spacer.gif)
| Vacuna contra el cáncer que contiene el gen del antígeno carcinoembrionario (ACE) en el virus de la variolovacuna. El virus de la variolovacuna se relaciona con el virus que se usa para elaborar la vacuna antivariólica. El ACE es un marcador tumoral. La vacuna ariolovacunal ACE puede ayudar al sistema inmunitario a reconocer las células que elaboran el ACE y destruirlas. |
![](https://webarchive.library.unt.edu/eot2008/20081010044217im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081010044217im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081010044217im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081010044217im_/http://www.nci.nih.gov/images/spacer.gif) |